Navigation Links
NeurogesX Receives Notice of Allowance for Patent Covering NGX-1998 Capsaicin Topical Liquid
Date:4/28/2011

ass="discStyle" type="disc">
  • Patents relating to capsaicin prodrugs entitled, "TRPV1 Agonist Compounds and Methods for Making and Using the Same," have issued in the United Stated and Mexico.

    • Patents relating to capsaicin oils entitled, "Oils of Capsaicinoids and Methods of Making and Using the Same," have issued in the United States, throughout Europe and Eurasia.

    • With respect to the skin cleansing gel, which is a component of the Qutenza treatment kit and is used to remove residual capsaicin from the skin after a Qutenza treatment, patents entitled, "Compositions and Kits for the Removal of Irritating Compounds from Bodily Surfaces," have issued in Eurasia and Japan.  

    • A patent relating to a capsaicin patch including specific penetration enhancers entitled, "Device for Delivery of TRPV1 Agonists," has issued in South Africa.

    About NeurogesX, Inc.

    NeurogesX, Inc. (Nasdaq: NGSX) is a San Francisco Bay Area-based biopharmaceutical company focused on developing and commercializing novel pain management therapies. NeurogesX was founded on the concept that use of prescription-strength capsaicin could help manage the pain associated with neuropathic pain conditions. Since its inception, NeurogesX has leveraged its passion to help people with pain to efficiently develop this concept, resulting in the commercial launch of Qutenza® (capsaicin) 8% patch in 2010. The Company continues to apply its knowledge and expertise in the development of other novel treatments for pain.

    The Company's lead product, Qutenza®, is a localized dermal delivery system containing prescription strength capsaicin that is currently approved in the United States and the European Union. Qutenza&#
    '/>"/>

    SOURCE NeurogesX
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
    2. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
    3. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
    4. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
    5. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
    6. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
    7. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
    8. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
    9. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
    10. NeurogesX to Present at JMP Securities Healthcare Focus Conference
    11. NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... a leader in the development of Chimeric Antigen Receptors ... cancers, today announced the completion of a series A ... -based healthcare private equity fund.   CARsgen ... new therapeutics for liver, lung, stomach and brain cancers. ... Hospital, the company plans to initiate clinical studies for ...
    (Date:11/26/2014)... DALLAS , November 25, 2014 ... Surgical Instruments Market by Power Source (Electric, Battery, ... Console, Cables, Blade, Burr, Cart), by Application (Orthopedic, ... 2019" published by MarketsandMarkets, the global Powered Surgical Instruments ... to $1.6 Billion in 2014 and is expected ...
    (Date:11/26/2014)... NEW YORK , Nov. 25, 2014 /PRNewswire/ ... with Covidien has been widely discussed in ... but it,s also creating a stronger leading player ... according to Kalorama Information.  The healthcare market research ... monitoring systems will feature a diverse set of ...
    Breaking Medicine Technology:CARsgen Completes Series A Financing 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3
    (Date:11/27/2014)... HealthDay Reporter WEDNESDAY, Nov. 26, 2014 (HealthDay ... and produces an immune system response that could protect people ... reported by the U.S. National Institutes of Health. The ... paves the way for field-testing it in the Ebola-stricken West ... January, said Dr. Anthony Fauci, director of the NIH,s National ...
    (Date:11/27/2014)... (PRWEB) November 27, 2014 Now that ... season has officially launched, Emassagechair.com has announced ... Monday Discount Event. , Negotiating on behalf of ... top massage chair brands, Emassagechair.com has generated significant buzz ... deals and biggest discounts yet. , Shoppers are excited ...
    (Date:11/27/2014)... November 27, 2014 “LAB.C” was featured on ... the latest and coolest technology products available to consumers. Mallory ... product review and shared with viewers the company ... and Android devices. , Consumers love portability and functionality. ... Cable Case for the iPhone5 and 5S has a portable ...
    (Date:11/27/2014)... (PRWEB) November 27, 2014 Aria ... Aria Health employees, prepared and donated 200 Thanksgiving ... Lutheran Settlement House , a non-profit, community-based organization ... living in Philadelphia. The dinners were assembled in ... Senior Center, and distributed to vulnerable low income ...
    (Date:11/27/2014)... (PRWEB) November 27, 2014 Ethane Web ... has announced online reputation management service. , ... comprehensive study about the world of internet marketing and ... Yahoo. , Ethane Web Technologies does not work ... first analyzes the project to reach a conclusion what ...
    Breaking Medicine News(10 mins):Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2Health News:Ethane Web Technologies Announces Online Reputation Management Service 2
    ... latest research shows that Viagra //(sildenafil) may also help ... breathe easier. Children diagnosed with pulmonary arterial hypertension ( ... high in the arteries that supply the lungs, leads ... if left untreated, could eventually lead to death of ...
    ... of vegetables in childhood lower risk// of stroke.This link ... a very interesting study published in the journal Heart. ... not just due to exposure to risk factors in ... an entire lifetime. Previous studies have suggested that diets ...
    ... The emergence of new disease like SARS, Ebola, Marburg and ... looked into from a global perspective. ,In an article ... US have suggested that instead of tackling these epidemics from ... should be tackled with a common health program for the ...
    ... thought of and may remain undetected because of this//, says ... of the spine is a disease that may affect young ... stiffness for a long time must be medically examined for ... relief from the condition for the children. Some symptoms of ...
    ... that is trying new approaches to the neuroblastoma patients, ... be more effective in children than the common procedure. ... feel that the cancer drug topotecancan must be fine ... not all doses are effective on everybody. Only less ...
    ... An interesting prospective study undertaken by the researchers at Massachusetts ... shown that higher intake of low-fat dairy may lower the ... II diabetes, either the body does not produce enough insulin ... the body to be able to use sugar. Type II ...
    Cached Medicine News:Health News:Association between childhood diet and stroke 2
    ...
    EDM Ventricular Drainage Kit, with Drip Chamber with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in ...
    Lumbar External Drainage System (LED) with Touhy needle is indicated for temporary access to the Lumbar Subarachnoid region as a means of draining cerebral spinal fluid (CSF) in order to reduce incre...
    Monitorr ICP external CSF drainage and monitoring system with patient line one way valve....
    Medicine Products: